Belenos Biosciences

Belenos

Belenos Biosciences develops long-acting therapies and bispecific antibodies to treat patients with chronic inflammatory and autoimmune diseases.

Apogee Therapeutics

This biotechnology company develops monoclonal antibody therapies for patients with inflammatory and immunological diseases, including atopic dermatitis, asthma and chronic obstructive pulmonary disease.

Aiolos Bio

This biopharmaceutical company develops monoclonal antibody therapies for patients suffering from respiratory and inflammatory conditions such as moderate-to-severe asthma.

Windward Bio

The company develops long-acting monoclonal antibodies for patients with serious respiratory and dermatological diseases, including severe asthma, chronic obstructive pulmonary disease and atopic dermatitis.

Caldera Therapeutics

This clinical-stage biotechnology company develops bispecific antibodies to treat patients with inflammatory bowel disease and other immune-mediated conditions.

Upstream Bio

The company develops monoclonal antibody therapies for patients with chronic inflammatory and respiratory diseases, including asthma and chronic rhinosinusitis.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Bionyra

This biopharmaceutical company develops monoclonal and bispecific antibodies for patients with severe immune-mediated inflammatory diseases, specifically inflammatory bowel disease and atopic dermatitis.